Abstract
suggested that α2-domain-deleted HLA-G2 could perform the HLA-G1 function
96
[15]. Recently, it was reported that HLA-G2 could bind to LILRB2, but not to 97 LILRB1, and prolong the survival of skin allografts in both non-transgenic (PIR-B
98
was expected to function as a receptor) and LILRB2-transgenic mice [16, 17] . purified by Superdex200 10/300 GL (GE Healthcare). 
4. Mice 151
Six-week-old DBA/1J male mice were purchased from Japan Charles River 
6. Evaluation of CIA

171
The clinical severity of arthritis (RA score) was recorded five times a week. The HLA-G2 dimer immunosuppressive effect was maintained over one month
212
Next, we assessed the function of HLA-G2 in vivo using CIA mice, which were Seven days after the second sensitization, non-progressive mice were selected, and 220 randomly divided into three groups. These mice were administered HLA-G2 protein 
225
Mice were administered 1.4 µg (high dose) or 0.14 µg (low dose) HLA-G2 in PBS, or
226
PBS alone as a negative control. The high dose group showed consistently lower RA 227 scores than the control group for more than one month ( Fig. 2A and B) . Of note, at the 228 last 3 days of the experimental period, differences in RA score between the high dose 229 and control groups was statistically significant ( Fig. 2A) . In contrast, the low dose (Fig. 2C) . The incidence of disease at the end point was 75% in the high dose 234 group compared with 92% in the control group and 100% in the low dose group; a 235 decrease of 18% and 25%, respectively (Fig. 2C) . The day at which the incidence was 236 50% was delayed in the high dose group (day 29) compared with the low dose group 237 (day 23) and the control group (day 24). The onset of disease in the low dose group was 238 suppressed only in the early period (Fig. 2C) . A comparison of the RA scores of each 239 limb indicated that although mice were administered HLA-G2 locally, it had a 240 generalized systemic effect (Fig. 3) . Even though the RA scores in the hind right paw of the high dose of HLA-G2 administered and the control groups were not different, the
242
RA scores of both front paws and the hind left paw were lower in the high dose groups 243 compared with the control group (Fig. 3) . Finally, the RA score of all four limbs in the 244 high dose group was lower compared with the control group.
245
Therefore, these results indicate that HLA-G2 had an immunosuppressive 246 effect that was dose-dependent in CIA mice. Any negative effects such as a phenotype
247
other than arthritis and weight loss were not observed after the administration of
248
HLA-G2 protein (Fig. 2D) . The mean body weight in the control and low dose groups 249 tended to be decreased compared with the high dose group because of severe arthritis.
251
In this study, we demonstrated that purified HLA-G2 recombinant proteins prepared 253 by the refolding method showed significant immunosuppressive effects in CIA mice.
254
As in the case of HLA-G1 [5], HLA-G2 also showed long-term generalized effects 255 from a single local administration (Figs. 2 and 3) . Furthermore, we identified that
256
HLA-G2 specifically bound to PIR-B, the murine homologue of human LILRB.
257
Because PIR-B is only expressed by APCs, the effects of HLA-G2 in mice are 
278
The specific binding affinity of HLA-G2 against PIR-B is stronger than that of the 
297
Taken together, our data suggests that HLA-G2/G6 functions as a tolerogenic 298 molecule similar to HLA-G1/G5 through its specific binding to LILRB2 in humans
299
and PIR-B in mice. Therefore, the HLA-G2/G6 proteins might be a useful 300 biopharmaceutical for the treatment of rheumatoid arthritis. 
